SINUGENIX

Serial Number 85072016
606

Registration Progress

Application Filed
Jun 25, 2010
Under Examination
Jun 5, 2012
Approved for Publication
Apr 10, 2012
Published for Opposition
Apr 10, 2012
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SINUGENIX
Previous Owner: SinuGenix, LLC
Classes: 005, 010, 011

Trademark Image

SINUGENIX

Basic Information

Serial Number
85072016
Filing Date
June 25, 2010
Published for Opposition
April 10, 2012
Abandonment Date
January 7, 2013
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 7, 2013
Classes
005 010 011

Rights Holder

SinuGenix, LLC

16
Address
Suite 260
5051 Highway Seven
Minneapolis, MN 55416

Ownership History

SinuGenix, LLC

Original Applicant
16
Minneapolis, MN

SinuGenix, LLC

Owner at Publication
16
Minneapolis, MN

Legal Representation

Attorney
Sherri L Rohlf

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

34 events
Date Code Type Description Documents
Jan 7, 2013 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jan 7, 2013 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jun 5, 2012 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 10, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 10, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 21, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 5, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Mar 2, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 20, 2012 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Feb 20, 2012 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 20, 2012 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 20, 2012 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Feb 20, 2012 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 31, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 31, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 27, 2012 PGRR O PETITION GRANTED - RESPONSE RECEIVED Loading...
Jan 12, 2012 APET A ASSIGNED TO PETITION STAFF Loading...
Dec 20, 2011 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 20, 2011 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Dec 16, 2011 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Dec 15, 2011 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
May 17, 2011 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 17, 2011 GNFR O FINAL REFUSAL E-MAILED Loading...
May 17, 2011 CNFR R FINAL REFUSAL WRITTEN Loading...
Apr 22, 2011 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 22, 2011 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 15, 2011 ALIE A ASSIGNED TO LIE Loading...
Apr 13, 2011 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 14, 2010 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 14, 2010 GNRT F NON-FINAL ACTION E-MAILED Loading...
Oct 14, 2010 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 30, 2010 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 30, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 29, 2010 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Allergy medications, Allergy eye drops, Allergy relief medications, namely, allergy prevention spray, allergy protective screens, allergy antigens; Antifungal creams for medical use; Antibiotics, antibiotic creams and ointments, antibiotic ophthalmological ointments and solutions, anti-inflammatory decongestants, antihistamine eye drops, moisturizing eye drops, antihistamine nasal sprays, antihistamines; Aromatherapy oils, other than essential oils for treating nasal congestion, fatigue and decreased immunity; Preparations for treatment of asthma; Medical cleansers for skin and wounds; Medical creams for skin care; Decongestants; Cough treatment preparations; Cough suppressants; Injectable epinephrine (EPI) pens and racemic epinephrine for inhalation therapy (nebulization); Nutritionally fortified water, namely, electrically charged water; Medicated hair care preparations; Herbs for medicinal purposes; Natural herbal supplements used in ayurvedic medicines; Homeopathic supplements; Diagnostic test patch for application to the skin for determining allergies; leukotriene inhibitors, namely, pharmaceutical preparations that blunt the inflammatory allergic and asthma inducing response; Moisturizing nasal sprays, moisturizing saline gels solutions for medical purposes; Antimicrobial coatings to treat the growth of mold, mildew, bacteria and fungus on various surfaces; Pharmaceutical preparations that reduce the viscosity of respiratory mucus; Nasal anticholinergic sprays, nasal decongestants, nasal rinse, nasal steroid spray; Nutraceuticals for use as a dietary supplement; Medications that reduce the release of acid to treat reflux and ulcers; H-2 histamine blockers, namely, medication that reduces the release of histamine; Pharmaceutical preparations for the treatment of dermatitis, urticaria, psoriasis, angioedema, bacterial, viral, fugal and yeast skin infections; Anti-viral medications for skin cleansers; Pain relief medications; cleaning for medical use, namely, sterile solutions for nebulizers; Inhalers filled with racemic epinephrine, long and short acting beta agonsists, inhaled corticosteroids and salmeterol; Customized anti-biotic preparations for use with nebulizers; Vitamins; mineral, dietary and nutritional supplements; Antibacterial, antiviral and anti-inflammatory pharmaceuticals engineered with silver particles and NANO technology; Pharmaceutical preparations in the form of gels and rinses for use as custom nasal prescription formulations and novel bacterial applications consisting of blends of antibiotics, anti-fungal agents and steroid combinations
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Respiratory masks for medical purposes; Medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems for custom nasal prescription formulations and novel bacterial applications consisting of blends of antibiotics, anti-fungal agents and steroid combinations which are available in various topical delivery systems including gels, rinses and nebulization devices of various sizes; Medical apparatus and units for dosage measuring and monitoring, namely, drug delivery devices and systems for use in measuring charged particles (activated water), nitric oxide gas, UV light and laser ionization delivery; External nasal dilators and internal nasal splints "springs" and internal nasal dilators; Nebulizers for respiration therapy; nasal irrigation vessel and mechanical installation device; Inhalers for medical purpose; Replacement parts for nebulizers, namely, mouthpieces, masks, chinstraps, filters and tubing; Spirometer/peak flow meters, namely, devices used to measure breathing capacity in asthmatics and chronic obstructive pulmonary disease patients; Instruments and apparatus provided empty for the inhalation of pharmaceuticals designed to deliver cleansing via balanced sterile saline solution into the respiratory and medications to improve ventilation by their various anti-inflammatory, anti-bacterial, anti-fungal, mucolytic and cronchi-dilatory effecters
First Use Anywhere: 0
First Use in Commerce: 0
Class 011
Air filtration installations; Air filtering installations, namely, gas phase and hybrid filters; HEPA filters for household use; HEPA vacuum cleaners for household purposes; Humidifiers; UV lamps
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 010 011